EUIPOProtect this trademark from copycats!
With our trademark monitoring alerts, you are automatically notified by email about copycats and free riders.
The Union trademark UPTEMPO was filed as Word mark on 05/12/2023 at the European Union Intellectual Property Office.
It was registered as a trademark on 09/21/2023.
The current status of the mark is "Trademark registered".
| Trademark form | Word mark |
| File reference | 018874525 |
| Application date | May 12, 2023 |
| Publication date | June 14, 2023 |
| Entry date | September 21, 2023 |
| Expiration date | May 12, 2033 |
Trademark owner
14 Schoolhouse Road,
08873 Somerset
US
08873 Somerset
US
Trademark representatives
De Kleetlaan 7A (4e verdieping) Pegasus Park
1831 Diegem
BE
goods and services
1
Cells and cell lines for scientific, laboratory or medical research; Reagents for scientific or medical research use; Biological and biochemical preparations, namely, plasmids, RNA and proteins for scientific, medical research, or research use; Cell culture reagents for scientific and research use; Stem cells for research or scientific purposes; Biological preparations for use in cell cultures other than for medical or veterinary use; Engineered proteins for use in scientific research and analysis relating to genetic diseases, gene therapy, and cell therapy; biochemicals and biologics, namely, engineered nucleic acids, viral vectors, non-viral vectors, gene therapy vectors, gene editing vectors, genetically modified cells, engineered proteins for multiplexed gene editing, mRNA and recombinant adeno-associated virus (AAV) vectors for delivery of therapeutic DNA or mRNA sequences to cells; biochemicals and biologics, namely antibody preparations, chimeric antigen receptor (CAR) T-cell preparations, T-cell preparations, tumor-infiltration lymphocyte (TIL) preparations, natural killer (NK) cell preparations, induced pluripotent stem cell (iPSC) preparations, mesenchymal stem cell (MSC) preparations; all of the aforementioned for use in scientific research and analysis
5
Cells and cell lines for medical or clinical use; Stem cells for medical or veterinary use; Engineered proteins for clinical use, medical use, clinical laboratory use and medical laboratory use relating to genetic diseases, gene therapy, and cell therapy; biochemicals and biologics, namely, engineered nucleic acids, viral vectors, non-viral vectors, gene therapy vectors, gene editing vectors, DNA plasmids, genetically modified cells, engineered proteins for multiplexed gene editing all for clinical use, medical use, clinical laboratory use, and medical laboratory use; biochemicals and biologics, namely mRNA and recombinant adeno-associated virus (AAV) vectors for delivery of therapeutic DNA or mRNA sequences to cells, antibody preparations, chimeric antigen receptor (CAR) T-cell preparations, T-cell preparations, tumor-infiltration lymphocyte (TIL) preparations, natural killer (NK) cell preparations, all for clinical use, medical use, clinical laboratory use, and medical laboratory use; biochemicals and biologics, namely, induced pluripotent stem cell (iPSC) preparations, mesenchymal stem cell (MSC) preparations, all for clinical use, medical use, clinical laboratory use, and medical laboratory use; Pharmaceutical preparations in the nature of viral systems, gene therapy systems, and nucleic acid delivery systems comprised of viral vectors, gene therapy vectors, nucleic acid delivery vectors, and cells used to deliver modified genetic material into other cells for medical purposes
40
Custom manufacture of cells and cell lines for use in viral vector production, and for diagnostic, medical and commercial applications in relation to cell and gene therapies
42
Pharmaceutical research and development; Gene therapy research; Cell therapy research; Scientific research
Trademark history
| Date | Document number | Area | Entry |
|---|---|---|---|
| April 30, 2024 | Change Representative, Published |
ID: 11018874525